Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Redeemable Convertible Preferred Stock	Class A and Class B common stock	Additional Paid-in Capital	Accumulated other comprehensive	Accumulated Deficit	Common Stock [Member] Class A and Class B common stock
Beginning balance at Dec. 31, 2019	$ (62,879)			$ 17,378		$ (80,257)
Beginning balance, Shares at Dec. 31, 2019							24,646,000
Temporary equity, beginning balance, Shares at Dec. 31, 2019		56,480,000
Temporary equity, beginning balance at Dec. 31, 2019		$ 137,991
Issuance of redeemable convertible preferred stock, net of issuance costs		$ 49,820
Issuance of redeemable convertible preferred stock, net of issuance costs, shares		5,237,000
Stock-based compensation expense	16,553			16,553
Exercise of stock options	3,637			3,637
Exercise of stock options, Shares							3,648,000
Vesting of early exercised stock options	136			136
Donation of common stock and repurchase of unvested stock options, Shares							(370,000)
Net loss	(24,567)					(24,567)
Ending balance at Dec. 31, 2020	(67,120)			37,704		(104,824)
Ending balance, Shares at Dec. 31, 2020							27,924,000
Temporary equity, ending balance, Shares at Dec. 31, 2020		61,717,000
Temporary equity, ending balance at Dec. 31, 2020		$ 187,811
Issuance of redeemable convertible preferred stock, net of issuance costs		$ 199,802
Issuance of redeemable convertible preferred stock, net of issuance costs, shares		6,247,000
Conversion of redeemable convertible preferred stock to common stock upon Direct Listing	387,613		$ 1	387,612
Temporary equity, Conversion of redeemable convertible preferred stock to common stock upon Direct Listing, Shares		(67,964,000)
Temporary equity, Conversion of redeemable convertible preferred stock to common stock upon Direct Listing		$ (387,613)
Conversion of redeemable convertible preferred stock to common stock upon Direct Listing, Shares							67,964,000
Stock-based compensation expense	34,773			34,773
Exercise of stock options	16,982			16,982
Exercise of stock options, Shares							10,301,000
Vesting of early exercised stock options	1,881			1,881
Vesting of restricted stock awards, Shares							2,617,000
Issuance of common stock in connection with an acquisition	7,402			7,402
Issuance of common stock in connection with an acquisition, Shares							1,070,000
Net loss	(74,983)					(74,983)
Ending balance at Dec. 31, 2021	306,548			486,354		(179,807)	$ 1
Ending balance, Shares at Dec. 31, 2021							109,876,000
Stock-based compensation expense	68,576			68,576
Exercise of stock options	$ 6,899			6,899
Exercise of stock options, Shares	2,498,763						2,499,000
Vesting of early exercised stock options	$ 2,323			2,323
Issuance of common stock under employee stock purchase plan, shares							350,000
Issuance of common stock under employee stock purchase plan	$ 4,738			$ 4,738
Donation of common stock and repurchase of unvested stock options, Shares	1,000			1,000			8,000
Vesting of restricted stock awards, Shares							1,482,000
Net loss	$ (93,377)					(93,377)
Other comprehensive loss, net	(754)				$ (754)
Cumulative impact of Topic 842 adoption	17					17
Ending balance at Dec. 31, 2022	$ 294,969			$ 568,889	$ (754)	$ (273,167)	$ 1
Ending balance, Shares at Dec. 31, 2022							114,199,000